Abstract
Current neurobiological concepts attribute a central role of the hippocampal formation in cognitive and affective processes. Recent studies indicate that the hippocampus is affected in human depression, and antidepressant drugs induce hippocampal adaptive changes that are thought to be associated with their therapeutic action. In the present study, we investigated the action of various antidepressant drugs on the activity of the septo-hippocampal system, its oscillatory activity in particular. The acute effects of the norepinephrine (NE) reuptake inhibitors reboxetine and desipramine, and the selective serotonin reuptake inhibitor fluvoxamine were evaluated. Extracellular single-unit recordings were performed from the medial septum/diagonal band of Broca (MS/DBv), with simultaneous hippocampal EEG recordings of anesthetized rats. Systemic administration of reboxetine synchronized hippocampal EEG, resulting in a significant increase in power at theta frequency, and an increase in frequency and power of gamma-wave activity. Parallel to EEG synchrony, reboxetine induced or enhanced theta oscillation of MS/DBv neurons. Oscillatory frequencies of MS/DBv neurons were identical, and phase locked to the corresponding hippocamapal theta frequencies. Under the same experimental conditions, reboxetine induced a two-fold increase in extracellular NE (but not serotonin) levels in the hippocampus as revealed by microdialysis. Desipramine, but not the serotonin reuptake inhibitor fluvoxamine, evoked responses similar to those of reboxetine regarding septo-hippocampal theta activity. The present findings indicate that even though both NE and serotonin reuptake inhibitors are clinically effective antidepressant drugs, their action on the septo-hippocampal oscillatory behavior is different. It is presumed that selective NE reuptake inhibitors could modulate various cognitive processes associated with hippocampal oscillatory activity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Aston-Jones G, Bloom FE (1981). Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1: 876–886.
Aston-Jones G, Rajkowski J, Cohen J (1999). Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46: 1309–1320.
Berridge CW (1998). Modulation of forebrain electroencephalographic activity and behavioral state by the locus ceruleus-noradrenergic system: involvement of the medial septal area. Adv Pharmacol 42: 744–748.
Berridge CW, Foote SL (1991). Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 11: 3135–3145.
Bijak M, Zahorodna A, Tokarski K (2001). Opposite effects of antidepressants and corticosterone on the sensitivity of hippocampal CA1 neurons to 5-HT1A and 5-HT4 receptor activation. Naunyn Schmiedebergs Arch Pharmacol 363: 491–498.
Bragin A, Jando G, Nadasdy Z, Hetke J, Wise K, Buzsáki G (1995). Gamma frequency (40–100 Hz) patterns in the hippocampus of the behaving rat. J Neurosci 15: 47–60.
Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS (2000). Hippocampal volume reduction in major depression. Am J Psychiatry 157: 115–118.
Bosker FJ, Klompmakers AA, Westenberg HGM (1995). Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34: 501–508.
Buzsaki G (2002). Theta oscillations in the hippocampus. Neuron 33: 325–340.
Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L et al (2002). Fluoxetine, but not other selective serotonin reuptake inhibitors, increases NE and dopamine extracellular levels in the prefrontal cortex. Psychopharmacology 160: 353–361.
Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M et al (2001). Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 98: 12796–12801.
Deweer B, Pillon B, Pochon JB, Dubois B (2001). Is the HM story only a ‘remote memory’? Some facts about hippocampus and memory in humans. Behav Brain Res 127: 209–224.
Ferguson JM, Mendels J, Schwartz GE (2002). Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression. Int Clin Psychopharmacol 17: 45–51.
Ford RD, Colom LV, Bland BH (1989). The classification of medial septum-diagonal band cells as theta-on or theta-off in relation to hippocampal EEG states. Brain Res 493: 269–282.
Gross DW, Gotman J (1999). Correlation of high-frequency oscillations with the sleep–wake cycle and cognitive activity in humans. Neuroscience 94: 1005–1018.
Haddjeri N, Blier P, de Montigny C (1998). Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci 18: 10150–10156.
Hajós M, Hoffmann WE (2000). Regulation of septo-hippocampal activity by 5-HT2C receptors. Soc Neurosci Abstr, Progr No. 690.6.
Hajós M, Richards CD, Szekely AD, Sharp T (1998). An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87: 95–108.
Hajós-Korcsok E, McTavish SF, Sharp T (2000). Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine. Eur J Pharmacol 407: 101–107.
Heckers S (2001). Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 11: 520–528.
Hindmarch I (1998). Effect of antidepressants on cognitive and psychomotor function: the lack of effect of reboxetine. Hum Psychopharmacol Clin 13(Suppl 1): S21–S27; FEB.
Holsboer F (2001). Stress, hypercorticolism and corticosteroid receptors in depression: implications for therapy. J Affect Dis 62: 77–91.
Jensen O, Tesche CD (2002). Frontal theta activity in humans increases with memory load in a working memory task. Eur J Neurosci 15: 1395–1399.
Jordan S, Kramer GL, Zukas PK, Moeller M, Petty F (1994). In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18: 294–297.
Kandel ER (2001). The molecular biology of memory storage: a dialogue between genes and synapses. Science 294: 1030–1038.
Kasper S, el Giamal N, Hilger E (2000). Reboxetine: the first selective noradrenaline reuptake inhibitor. Expert Opin Pharmacother 1: 771–782.
Kinney GG, Kocsis B, Vertes RP (1996). Medial septal unit firing characteristics following injections of 8-OH-DPAT into the median raphe nucleus. Brain Res 708: 116–122.
Krause M, Hoffmann WE, Hajós M (2003). Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats. Biol Psychiatry, in press.
Leranth C, Vertes RP (1999). Median raphe serotonergic innervation of medial septum/diagonal band of broca (MSDB) parvalbumin-containing neurons: possible involvement of the MSDB in the desynchronization of the hippocampal EEG. J Comp Neurol 410: 586–598.
L'Heureux R, Dennis T, Curet O, Scatton B (1986). Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic neurotransmission. J Neurochem 46: 1794–1801.
Marrosu F, Fornal CA, Metzler CW, Jacobs BL (1996). 5-HT1A agonists induce hippocampal theta activity in freely moving cats: role of presynaptic 5-HT1A receptors. Brain Res 739: 192–200.
Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A et al (2001). S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298: 565–580.
Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34: 13–25.
Orban G, Kiss T, Lengyel M, Erdi P (2001). Hippocampal rhythm generation: gamma-related theta-frequency resonance in CA3 interneurons. Biol Cybern 84: 123–132.
Parra P, Gulyas AI, Miles R (1998). How many subtypes of inhibitory cells in the hippocampus? Neuron 20: 983–993.
Penttonen M, Kamondi A, Acsady L, Buzsaki G (1998). Gamma frequency oscillation in the hippocampus of the rat: intracellular analysis in vivo. Eur J Neurosci 10: 718–728.
Perry KW, Fuller RW (1997). Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats. J Neural Transm 104: 953–966.
Raghavachari S, Kahana MJ, Rizzuto DS, Caplan JB, Kirschen MP, Bourgeois B et al (2001). Gating of human theta oscillations by a working memory task. J Neurosci 21: 3175–3183.
Rammsayer TH, Hennig J, Haag A, Lange N (2001). Effects of noradrenergic activity on temporal information processing in humans. Q J Exp Psychol B 54: 247–258.
Sacchetti G, Bernini M, Bianchetti A, Parini S, Invernizzi RW, Samanin R (1999). Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br J Pharmacol 128: 1332–1338.
Sapolsky RM (2000). The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48: 755–765.
Seager MA, Johnson LD, Chabot ES, Asaka Y, Berry SD (2002). Oscillatory brain states and learning: Impact of hippocampal theta-contingent training. Proc Natl Acad Sci USA 99: 1616–1620.
Sheline Y, Wang P, Gado M, Csernansky J, Vannier M (1996). Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93: 3908–4003.
Siepmann M, Muck-Weymann M, Joraschky P, Kirch W (2001). The effects of reboxetine on autonomic and cognitive functions in healthy volunteers. Psychopharmacology (Berl) 157: 202–207.
Tanum L (2000). Reboxetine: tolerability and safety profile in patients with major depression. Acta Psychiatr Scand 402(Suppl): 37–40.
Traub RD, Whittington MA, Colling SB, Buzsaki G, Jefferys JG (1996). Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo. J Physiol 493: 471–484.
Vertes RP, Kocsis B (1997). Brainstem-diencephalo-septohippocampal systems controlling the theta rhythm of the hippocampus. Neuroscience 81: 893–926.
Whittington MA, Faulkner HJ, Doheny HC, Traub RD (2000). Neuronal fast oscillations as a target site for psychoactive drugs. Pharmacol Ther 86: 171–190.
Wong EH, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP et al (2000). Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol Psychiatry 47: 818–829.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hajós, M., Hoffmann, W., Robinson, D. et al. Norepinephrine but not Serotonin Reuptake Inhibitors Enhance Theta and Gamma Activity of the Septo-Hippocampal System. Neuropsychopharmacol 28, 857–864 (2003). https://doi.org/10.1038/sj.npp.1300116
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300116
Keywords
This article is cited by
-
In vivo electrophysiological recordings of the effects of antidepressant drugs
Experimental Brain Research (2019)
-
Gamma oscillations as a biomarker for major depression: an emerging topic
Translational Psychiatry (2018)
-
Modulation of induced frontocentral theta (Fm-θ) event-related (de-)synchronisation dynamics following mindfulness-based cognitive therapy in Major Depressive Disorder
Cognitive Neurodynamics (2014)
-
Serotonergic modulation of hippocampal theta activity in relation to hippocampal information processing
Experimental Brain Research (2013)
-
Coupling changes in cortical and pontine sigma and theta frequency oscillations following monoaminergic lesions in rat
Sleep and Breathing (2011)
